· Weekly signal · RVMD

Revolution Medicines Inc (RVMD) carries a 96.2% 12-week surge into July

Momentum measures remain firm in weekly context, though lighter turnover leaves confirmation less complete.

Weekly market chart context for Revolution Medicines Inc, a biotechnology oncology company.

Revolution Medicines Inc (RVMD) closed the latest week at $189.24, up 3.9% for the week as the weekly price path over 52 weeks extended a larger biotech advance.

The move is supported by a 26.8% four-week gain, an active trend reading and Market Dynamics confirmation at 1.15. The complication is participation: weekly volume was 14.6 million shares versus a 16.8 million 13-week average.